Operating profit before amortization: Mustang Bio, Inc. (MBIO)
Volatility in absolute EBITDA levels highlights the complexities of implementing ESG standards within gene therapy production for Mustang Bio, Inc. (MBIO). The value of 0.00 expresses the metric level, stabilizing the trend through partnerships with pharma behemoths and CAR-T developments. Cyclical resilience is driven by demand for innovation and the progress of clinical trials, which smooths the price action on the chart and helps avoid purchasing an overvalued asset.
%20Operating%20profit%20EBITDA&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_MBIO_-_Mustang-Bio-Inc._-_Operating-profit-EBITDA "Mustang Bio Corp - MBIO Operating profit before depreciation charges (period 11/23/2025 - 11/12/2026) | 👁️GURU.Markets👁️")
Mustang Bio (MBIO) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- balance sheet net asset value indicators:
- business debt structure and liquidity details:
Debt to Equity Mustang Bio, Inc.|MBIO - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Mustang Bio Inc|MBIO - Company Debts|Debts to Book Value Mustang Bio|MBIO - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Mustang Bio|Interim Coverage Ratio mustangbio.com
- net income and valuation ratios data:
MBIO - Company Net Income|Net Profit Forecast Mustang Bio, Inc.|MBIO - P/E Multiple|Projected Price to Earnings Mustang Bio Inc|MBIO - Price/Earnings to Growth Multiple|Total Company Value to Operating Income Before Depreciation Ratio Mustang Bio|MBIO - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Mustang Bio|MBIO - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months mustangbio.com|MBIO - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Mustang Bio, Inc.
Analysis of all company metrics:Mustang Bio, Inc.
Absolute operating profit measures the cash flow from core operations before depreciation and taxes, determining the business's ability to function autonomously without external borrowing. By analyzing the total EBITDA for the period, an investor assesses the financial stability of Mustang Bio, Inc. (MBIO) in the context of costs associated with creating CAR-T cell therapies and developing strategic partnerships with leading gene therapy research centers.
Competitor analysis for Mustang Bio, Inc.
Operating profit EBITDA Tempus TEM|QGEN - Profit before payment of interest, taxes and amortization|IONS (ionispharma.com) - Operating profit before amortization|RGEN: Operating profit EBITDA|Operating profit before depreciation charges Avidity Biosciences Inc RNA|Operating profit before deduction of amortization CRSP|WGS: Income before deduction of interest, taxes and amortization|Operating profit EBITDA RARE|Profit before payment of interest, taxes and amortization BEAM (beamtx.com)|Operating profit EBITDA SRPT (Sarepta)|Operating income before deduction of amortization Twist Bioscience Inc (TWST)|TXG - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Intellia Corp|STOK (Stoke Therapeutics) - Operating profit before deduction of amortization|biolifesolutions.com - Income before deduction of interest, taxes and amortization|WVE (Wave Life Sciences Ltd.) - Operating profit EBITDA|Maze Therapeutics, Inc. (MAZE) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Sionna Pharma (SION)|Prime Medicine Bio - Operating profit before amortization|Operating profit EBITDA TSHA (Taysha Gene Therapies)|QURE - Operating profit before deduction of amortization|MGTX: Operating profit before deduction of amortization|Operating income before deduction of amortization REGENXBIO Inc RGNX|Solid Bio (SLDB) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Ocugen Pharma|PACB (Pacific Biosciences) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization BNTC|Operating profit EBITDA DSGN|Operating income before deduction of amortization Rocket Pharma|Profit before payment of interest, taxes and amortization 4D Molecular Therapeutics Inc FDMT|Lexeo Therapeutics Inc. (LXEO) - Profit before interest, taxes and amortization|Korro Bio, Inc - Operating profit EBITDA|EDIT (editasmedicine.com) - Operating profit before amortization|Silence Therapeutics plc (SLN) - Profit before payment of interest, taxes and amortization|Operating profit before amortization PRQR|CDXS (Codexis Inc) - Operating profit EBITDA|Operating profit EBITDA Sangamo BioSciences|Profit before payment of interest, taxes and amortization Nautilus Biotechnology (NAUT)|Operating profit before deduction of amortization metagenomi.co MGX|Precision BioSciences, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Generation Bio Co GBIO|BOLD - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Exicure, Inc. XCUR|IMNN (imunon.com) - Operating profit before deduction of amortization|PHIO: Company profit before taxes, interest and amortization|RNAZ (TransCode Therapeutics Inc.) - Operating profit EBITDA|Operating profit EBITDA Bionano|Profit before payment of interest, taxes and amortization Applied DNA (APDN)|bluebird bio, Inc - Operating profit before amortization|Operating profit EBITDA IPA (ImmunoPrecise Antibodies Ltd.)|Operating profit before depreciation charges omegatherapeutics.com|OMIC: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization RGLS (Regulus Therapeutics, Inc.)|SYRS: Operating profit EBITDA|TBIO (Telesis Bio, Inc) - Profit before payment of interest, taxes and amortization|TCON (TRACON Pharmaceuticals) - Operating profit EBITDA|unitybiotechnology.com (UBX) - Operating income before deduction of amortization
